ReNeuron

100 articles about ReNeuron

• Stem Cell Specialist ReNeuron Raises $105 Million to Fund Research Through 2019

  7/10/2015

• Benitec, Inc. Enters Into Strategic Collaboration With ReNeuron To Develop Cellular Therapies

  6/22/2015

• ReNeuron Stem Cell Firm Relocates in £33.2 Million Investment

  7/22/2013

• The Team of TheBioTechPanel Inc. is Proud to Announce the Addition of ReNeuron's Interview to Its' Internet-TV site, TheBioTechPanel-TV.com

  10/11/2012

• ReNeuron 2011 AGM Trading Update

  9/15/2011

• ReNeuron Gives Update on Stroke Clinical Trial

  9/13/2011

• ReNeuron Board Appointments

  7/20/2011

• ReNeuron - Preliminary Results for the Year Ended 31 March 2011

  6/30/2011

• ReNeuron Signs License Agreement with Leading US Eye Research Institute to Develop Stem Cell Therapies for Diseases of the Retina

  6/16/2011

• ReNeuron Flags Participation at Forthcoming London Public Stem Cell Forum and Other Key UK Conferences

  3/4/2011

• ReNeuron Gives Update on Stroke Clinical Trial

  3/3/2011

• NeuralStem Inc. Settles Litigation Against ReNeuron

  1/28/2011

• ReNeuron - First Admission

  12/17/2010

• ReNeuron Announces First Patient Treated in Landmark Stroke Stem Cell Clinical Trial

  11/16/2010

• ReNeuron Cited As A Regenerative Medicine Leader In Uk Government’s "Best Of British" Publication

  3/22/2010

• ReNeuron Signs Further Stem Cell Manufacturing Contracts With Angel Biotechnology Ltd For Stroke Clinical Trial

  3/18/2010

• ReNeuron Presents Key Pre-Clinical Efficacy Data With Ren009 Stem Cell Therapy At Leading UK Diabetes Conference

  3/3/2010

• ReNeuron Announces Fundraising of €5.7 Million (7.3M USD)

  2/22/2010

• ReNeuron And Schepens Eye Research Institute Receive Unrestricted Industrial Grant To Support US Retinal Stem Cell Collaboration

  2/18/2010

• ReNeuron Receives Final Regulatory Approval to Commence Landmark Stroke Clinical Trial in UK

  2/10/2010